Survival of Macroencapsulated Allogeneic Parathyroid Tissue One Year after Transplantation in Nonimmunosuppressed Humans-Reference-Cited by-同舟云学术

Survival of Macroencapsulated Allogeneic Parathyroid Tissue One Year after Transplantation in Nonimmunosuppressed Humans

Published:2001-10 Issue:7 Volume:10 Page:591-599
ISSN:0963-6897
Container-title:Cell Transplantation
language:en
Short-container-title:Cell Transplant

Author:

Tibell Annika¹,Rafael Ehab¹,Wennberg Lars¹,Nordenström Jörgen²,Bergström Mats³,Geller Robin L.⁴,Loudovaris Thomas⁴,Johnson Robert C.⁴,Brauker James H.⁴,Neuenfeldt Steven⁴,Wernerson Annika¹

Affiliation:

1. Departments of Transplantation Surgery, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

2. Departments of Surgery, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

3. Departments of Clinical Chemistry, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden

4. Baxter Healthcare Corporation, Round Lake, IL

Publisher

SAGE Publications

Subject

Transplantation,Cell Biology,Biomedical Engineering

Link

http://journals.sagepub.com/doi/pdf/10.3727/000000001783986404

Reference26 articles.

1. Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients

2. Growth and function of human parathyroid tissue transplanted to athymic mice

3. Inflammatory Response to Implants

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia within subcutaneously implanted macroencapsulation devices limits the viability and functionality of densely loaded islets;Frontiers in Transplantation;2023-11-17

2. Electrocatalytic on-site oxygenation for transplanted cell-based-therapies;Nature Communications;2023-11-09

3. Recent advances in endocrine organoids for therapeutic application;Advanced Drug Delivery Reviews;2023-08

4. Electrocatalytic on-site oxygenation for transplanted cell-based-therapies;2023-06-07

5. Scaffolds for Encapsulation of Stem Cell-Derived β Cells;Pluripotent Stem Cell Therapy for Diabetes;2023